Medical Research Articles Published in January 2013

With a Free Docphin Account, you create a custom list of medical research journal sources that are easy to navigate, search our extensive databse of articles, save and organize your articles into folders, set up alerts to be notificed of research articles that match your interests ... and much more.

Login or Register
01/01/2013
Novel risk factors related to stable angina. (PubMedID: 23016718) Current pharmaceutical design
01/01/2013
Is there a role for antioxidants in the treatment of stable angina? (PubMedID: 23016719) Current pharmaceutical design
01/01/2013
Infections and atheromatous plaque: current therapeutic implications. (PubMedID: 23016720) Current pharmaceutical design
01/01/2013
The role of microRNAs in the initiation and progression of stable atheromatous plaque. (PubMedID: 23016721) Current pharmaceutical design
01/01/2013
Novel strategies to target inflammatory processes in atherosclerosis. (PubMedID: 23016722) Current pharmaceutical design
01/01/2013
Refractory angina pectoris: lessons from the past and current perspectives. (PubMedID: 23016723) Current pharmaceutical design
01/01/2013
Editorial: stable angina pectoris: novel therapeutic insights. (PubMedID: 23016724) Current pharmaceutical design
01/01/2013
Diagnostic tests for the detection of human papillomavirus-associated cervical lesions. (PubMedID: 23016768) Current pharmaceutical design
01/01/2013
HPV infections: basis of neoplastic transformation and related molecular tests. (PubMedID: 23016769) Current pharmaceutical design
01/01/2013
HPV pathway profiling: HPV related cervical dysplasia and carcinoma studies. (PubMedID: 23016770) Current pharmaceutical design
01/01/2013
Predictors and clinical implications of HPV reservoire districts for genital tract disease. (PubMedID: 23016771) Current pharmaceutical design
01/01/2013
HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology. (PubMedID: 23016772) Current pharmaceutical design
01/01/2013
Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screening. (PubMedID: 23016773) Current pharmaceutical design
01/01/2013
Role of cell cycle biomarkers in human papillomavirus related uterine lesions. (PubMedID: 23016774) Current pharmaceutical design
01/01/2013
Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinoma. (PubMedID: 23016775) Current pharmaceutical design
01/01/2013
The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significance. (PubMedID: 23016776) Current pharmaceutical design
01/01/2013
The problem of false-positive human papillomavirus DNA tests in cervical screening. (PubMedID: 23016777) Current pharmaceutical design
01/01/2013
Detection of residual/recurrent cervical disease after successful LEEP conization: the possible role of mRNA-HPV test. (PubMedID: 23016778) Current pharmaceutical design
01/01/2013
The mRNA-HPV test utilization in the follow up of HPV related cervical lesions. (PubMedID: 23016779) Current pharmaceutical design
01/01/2013
Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe? (PubMedID: 23016780) Current pharmaceutical design
01/01/2013
Risk of cervical cancer after HPV vaccination. (PubMedID: 23016781) Current pharmaceutical design
01/01/2013
The present and future of cervical cancer screening programmes in Europe. (PubMedID: 23016782) Current pharmaceutical design
01/01/2013
Prevalence and distribution of human papillomavirus genotype in south eastern Italy, in the period 2006-2011: implications for intervention. (PubMedID: 23016783) Current pharmaceutical design
01/01/2013
Mapping myeloperoxidase to identify its promiscuity properties using docking and molecular dynamics simulations. (PubMedID: 23016839) Current pharmaceutical design
01/01/2013
FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNA. (PubMedID: 23016840) Current pharmaceutical design
01/01/2013
Exploring QSARs of vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitors by MLR, PLS and PC-ANN. (PubMedID: 23016841) Current pharmaceutical design
01/01/2013
Computational approaches for ligand discovery and design in class-A G protein- coupled receptors. (PubMedID: 23016842) Current pharmaceutical design
01/01/2013
Desirability-based multi-criteria virtual screening of selective antimicrobial cyclic ß-hairpin cationic peptidomimetics. (PubMedID: 23016843) Current pharmaceutical design
01/01/2013
Molecular modeling and virtual screening of DNA methyltransferase inhibitors. (PubMedID: 23016844) Current pharmaceutical design
01/01/2013
Modeling of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one derivatives by several conformational searching tools and molecular docking. (PubMedID: 23016845) Current pharmaceutical design
01/01/2013
Macromolecular structure comparison and docking: an algorithmic review. (PubMedID: 23016846) Current pharmaceutical design
01/01/2013
Scoring functions for prediction of protein-ligand interactions. (PubMedID: 23016847) Current pharmaceutical design
01/01/2013
Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. (PubMedID: 23016851) Current pharmaceutical design
01/01/2013
Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism. (PubMedID: 23016852) Current pharmaceutical design
01/01/2013
New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. (PubMedID: 23016853) Current pharmaceutical design
01/01/2013
Regulation and function of DNA and histone methylations. (PubMedID: 23016854) Current pharmaceutical design
01/01/2013
Exploring patterns of epigenetic information with data mining techniques. (PubMedID: 23016855) Current pharmaceutical design
01/01/2013
microRNA biogenesis pathway as a therapeutic target for human disease and cancer. (PubMedID: 23016856) Current pharmaceutical design
01/01/2013
Rejuvenating sirtuins: the rise of a new family of cancer drug targets. (PubMedID: 23016857) Current pharmaceutical design
01/01/2013
ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6. (PubMedID: 23016858) Current pharmaceutical design
01/01/2013
Immunoproteasome in cancer and neuropathologies: a new therapeutic target? (PubMedID: 23016859) Current pharmaceutical design
01/01/2013
Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms. (PubMedID: 23016860) Current pharmaceutical design
01/01/2013
Glycogen synthase kinase 3 as an anticancer drug target: novel experimental findings and trends in the design of inhibitors. (PubMedID: 23016861) Current pharmaceutical design
01/01/2013
Wnt/beta-catenin signaling and small molecule inhibitors. (PubMedID: 23016862) Current pharmaceutical design
01/01/2013
Accessing cancer metabolic pathways by the use of microarray technology. (PubMedID: 23016863) Current pharmaceutical design
01/01/2013
Fibroblast growth factor receptor inhibitors. (PubMedID: 23016864) Current pharmaceutical design
01/01/2013
Colorectal cancer microenvironment: among nutrition, gut microbiota, inflammation and epigenetics. (PubMedID: 23016865) Current pharmaceutical design
01/01/2013
Editorial: cross-talking metabolism and epigenetics in anti-cancer drug design. (PubMedID: 23016866) Current pharmaceutical design
01/01/2013
T cell replicative senescence in human aging. (PubMedID: 23061726) Current pharmaceutical design
01/01/2013
Impact of cellular senescence in aging and cancer. (PubMedID: 23061727) Current pharmaceutical design
01/01/2013
Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. (PubMedID: 23061728) Current pharmaceutical design
01/01/2013
Peripheral mononuclear cell rejuvenation for senescence surveillance in Alzheimer disease. (PubMedID: 23061729) Current pharmaceutical design
01/01/2013
Platelets in Alzheimer's disease-associated cellular senescence and inflammation. (PubMedID: 23061730) Current pharmaceutical design
01/01/2013
Good, bad, mobile elements: genome's most successful "parasites" as emerging players in cell and organismal aging. (PubMedID: 23061731) Current pharmaceutical design
01/01/2013
Metallothioneins, ageing and cellular senescence: a future therapeutic target. (PubMedID: 23061732) Current pharmaceutical design
01/01/2013
Human papillomavirus DNA and E6/E7 mRNA testing as triage in liquid-based cytology samples from primary screening. (PubMedID: 23072430) Current pharmaceutical design
01/01/2013
Binding site detection and druggability prediction of protein targets for structure-based drug design. (PubMedID: 23082974) Current pharmaceutical design
01/01/2013
Rational drug design: the search for Ras protein hydrolysis intermediate conformation inhibitors with both affinity and specificity. (PubMedID: 23082975) Current pharmaceutical design
01/01/2013
Selective induction of apoptosis: promising therapy in pancreatic cancer. (PubMedID: 23082976) Current pharmaceutical design
01/01/2013
Role of bivalent cations in structural stabilities of new drug targets--vaccinia-related kinases (VRK) from molecular dynamics simulations. (PubMedID: 23082977) Current pharmaceutical design
01/01/2013
The challenge to the rule of homology modeling: folding mechanism study of protein G(A) and G(B) with high sequence identity but different native structures. (PubMedID: 23082978) Current pharmaceutical design
01/01/2013
Binding free energy estimation for protein-ligand complex based on MM-PBSA with various partial charge models. (PubMedID: 23082979) Current pharmaceutical design
01/01/2013
Exploring the relationship between sequences, structures, dynamical behaviors and functions of new type protein drugs: DARPins. (PubMedID: 23082980) Current pharmaceutical design
01/01/2013
Targeting the nuclear transport machinery by rational drug design. (PubMedID: 23082981) Current pharmaceutical design
01/01/2013
Rational drug design with the aid of molecular modeling and bioinformatics. (PubMedID: 23082982) Current pharmaceutical design
01/01/2013
Development of small molecule HIV-1 fusion inhibitors: linking biology to chemistry. (PubMedID: 23092276) Current pharmaceutical design
01/01/2013
Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion. (PubMedID: 23092277) Current pharmaceutical design
01/01/2013
From the chemistry of epoxy-sugar nucleosides to the discovery of anti-HIV agent 4'-ethynylstavudine-Festinavir. (PubMedID: 23092278) Current pharmaceutical design
01/01/2013
Blocking HIV-1 replication by targeting the Tat-hijacked transcriptional machinery. (PubMedID: 23092279) Current pharmaceutical design
01/01/2013
Inhibitors of HIV-1 entry. (PubMedID: 23092280) Current pharmaceutical design
01/01/2013
Quinoline-based HIV integrase inhibitors. (PubMedID: 23092281) Current pharmaceutical design
01/01/2013
Anti-HIV drug development: structural features and limitations of present day drugs and future challenges in the successful HIV/AIDS treatment. (PubMedID: 23092282) Current pharmaceutical design
01/01/2013
The current status and challenges in the development of fusion inhibitors as therapeutics for HIV-1 infection. (PubMedID: 23092283) Current pharmaceutical design
01/01/2013
Discovery of small molecule fusion inhibitors targeting HIV-1 gp41. (PubMedID: 23092284) Current pharmaceutical design
01/01/2013
Editorial: the development of novel inhibitors for the treatment of HIV infection. (PubMedID: 23092285) Current pharmaceutical design
01/01/2013
Molecular aspects of the RT/drug interactions. Perspective of dual inhibitors. (PubMedID: 23092286) Current pharmaceutical design
01/01/2013
Sexual dimorphism in renal heme-heme oxygenase system in the streptozotocin diabetic rats. (PubMedID: 23092315) Current pharmaceutical design
01/01/2013
Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs design. (PubMedID: 23092316) Current pharmaceutical design
01/01/2013
Novel penetrating cations for targeting mitochondria. (PubMedID: 23092317) Current pharmaceutical design
01/01/2013
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis. (PubMedID: 23092318) Current pharmaceutical design
01/01/2013
Hydrogen sulfide prevents hyperoxia-induced lung injury by downregulating reactive oxygen species formation and angiopoietin-2 release. (PubMedID: 23092319) Current pharmaceutical design
01/01/2013
Periodontitis and redox status: a review. (PubMedID: 23092320) Current pharmaceutical design
01/01/2013
Carbon Monoxide and the brain: time to rethink the dogma. (PubMedID: 23092321) Current pharmaceutical design
01/01/2013
Regulation of autophagy in oxygen-dependent cellular stress. (PubMedID: 23092322) Current pharmaceutical design
01/01/2013
Reactive oxygen and nitrogen species in the renal ischemia/reperfusion injury. (PubMedID: 23092323) Current pharmaceutical design
01/01/2013
Synergistic effect of L-Carnosine and EGCG in the prevention of physiological brain aging. (PubMedID: 23092324) Current pharmaceutical design
01/01/2013
Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells. (PubMedID: 23092325) Current pharmaceutical design
01/01/2013
Ellagic acid: cytodifferentiating and antiproliferative effects in human prostatic cancer cell lines. (PubMedID: 23092326) Current pharmaceutical design
01/01/2013
Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). (PubMedID: 23092327) Current pharmaceutical design
01/01/2013
Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity. (PubMedID: 23092328) Current pharmaceutical design
01/01/2013
Pharmacological and molecular targets in cellular redox status maintenance. (PubMedID: 23092329) Current pharmaceutical design
01/01/2013
Roles of miRNA in the initiation and development of colorectal carcinoma. (PubMedID: 23092337) Current pharmaceutical design
01/01/2013
Therapeutically targeting microRNAs in liver cancer. (PubMedID: 23092338) Current pharmaceutical design
01/01/2013
Epigenetic deregulation of microRNAs: new opportunities to target oncogenic signaling pathways in hepatocellular carcinoma. (PubMedID: 23092339) Current pharmaceutical design
01/01/2013
The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies. (PubMedID: 23092340) Current pharmaceutical design
01/01/2013
miRNAs in gastrointestinal and liver cancers: their perspectives and clinical applications. (PubMedID: 23092341) Current pharmaceutical design
01/01/2013
MicroRNAs and esophageal cancer--implications for pathogenesis and therapy. (PubMedID: 23092342) Current pharmaceutical design
01/01/2013
MicroRNA involvement in gastrointestinal stromal tumor tumorigenesis. (PubMedID: 23092343) Current pharmaceutical design
01/01/2013
The expression patterns and clinical significance of microRNAs in liver diseases and hepatocellular carcinoma. (PubMedID: 23092345) Current pharmaceutical design
01/01/2013
MicroRNA dysregulation in gastric cancer. (PubMedID: 23092346) Current pharmaceutical design
01/01/2013
MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. (PubMedID: 23092347) Current pharmaceutical design
01/01/2013
MicroRNAs: small molecules with a potentially role in oral squamous cell carcinoma. (PubMedID: 23092348) Current pharmaceutical design
01/01/2013
MicroRNA in the pathogenesis and prognosis of esophageal cancer. (PubMedID: 23092349) Current pharmaceutical design
01/01/2013
Editorial: miRNA in the pathogenesis and therapy for gastrointestinal and hepatic cancers. (PubMedID: 23092350) Current pharmaceutical design
01/01/2013
Antimycobacterial activity of quaternary pyridinium salts and pyridinium N-oxides--review. (PubMedID: 23116306) Current pharmaceutical design
01/01/2013
Advances in clinical study of curcumin. (PubMedID: 23116307) Current pharmaceutical design
01/01/2013
Recent progress in studying curcumin and its nano-preparations for cancer therapy. (PubMedID: 23116308) Current pharmaceutical design
01/01/2013
Curcumin nanomedicine: a road to cancer therapeutics. (PubMedID: 23116309) Current pharmaceutical design
01/01/2013
The clinical applications of curcumin: current state and the future. (PubMedID: 23116310) Current pharmaceutical design
01/01/2013
A review of therapeutic effects of curcumin. (PubMedID: 23116311) Current pharmaceutical design
01/01/2013
Perspectives on new synthetic curcumin analogs and their potential anticancer properties. (PubMedID: 23116312) Current pharmaceutical design
01/01/2013
Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes. (PubMedID: 23116313) Current pharmaceutical design
01/01/2013
Curcumin: from chemistry to chemistry-based functions. (PubMedID: 23116314) Current pharmaceutical design
01/01/2013
Chemical and structural features influencing the biological activity of curcumin. (PubMedID: 23116315) Current pharmaceutical design
01/01/2013
Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. (PubMedID: 23116316) Current pharmaceutical design
01/01/2013
Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). (PubMedID: 23116317) Current pharmaceutical design
01/01/2013
Recent progress and novel insights in curcumin research "from chemistry to clinical use". (PubMedID: 23116318) Current pharmaceutical design
01/01/2013
Intranasal drug delivery to the central nervous system: present status and future outlook. (PubMedID: 23116337) Current pharmaceutical design
01/01/2013
D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy. (PubMedID: 23116391) Current pharmaceutical design
01/01/2013
Inhibitor design for monoamine oxidases. (PubMedID: 23116392) Current pharmaceutical design
01/01/2013
Is renalase a novel player in catecholaminergic signaling? The mystery of the catalytic activity of an intriguing new flavoenzyme. (PubMedID: 23116393) Current pharmaceutical design
01/01/2013
Riboflavin analogs as antiinfectives: occurrence, mode of action, metabolism and resistance. (PubMedID: 23116394) Current pharmaceutical design
01/01/2013
Targeting UDP-galactopyranose mutases from eukaryotic human pathogens. (PubMedID: 23116395) Current pharmaceutical design
01/01/2013
Methylenetetrahydrofolate reductase: biochemical characterization and medical significance. (PubMedID: 23116396) Current pharmaceutical design
01/01/2013
Redox proteins as targets for drugs development against pathogens. (PubMedID: 23116397) Current pharmaceutical design
01/01/2013
Chemical nature and reaction mechanisms of the molybdenum cofactor of xanthine oxidoreductase. (PubMedID: 23116398) Current pharmaceutical design
01/01/2013
Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase. (PubMedID: 23116399) Current pharmaceutical design
01/01/2013
The oxido-reductase activity of the apoptosis inducing factor: a promising pharmacological tool? (PubMedID: 23116400) Current pharmaceutical design
01/01/2013
The prokaryotic FAD synthetase family: a potential drug target. (PubMedID: 23116401) Current pharmaceutical design
01/01/2013
Biosynthesis of flavin cofactors in man: implications in health and disease. (PubMedID: 23116402) Current pharmaceutical design
01/01/2013
1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents. (PubMedID: 23116403) Current pharmaceutical design
01/01/2013
Flavoproteins and flavoenzymes with biomedical and therapeutic impact. (PubMedID: 23116404) Current pharmaceutical design
01/01/2013
Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry. (PubMedID: 23131184) Current pharmaceutical design
01/01/2013
Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles. (PubMedID: 23140451) Current pharmaceutical design
01/01/2013
Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask). (PubMedID: 23140452) Current pharmaceutical design
01/01/2013
Cell-penetrating peptides as nucleic acid delivery systems: from biophysics to biological applications. (PubMedID: 23140453) Current pharmaceutical design
01/01/2013
Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophy. (PubMedID: 23140454) Current pharmaceutical design
01/01/2013
Intracellular fate of peptide-mediated delivered cargoes. (PubMedID: 23140455) Current pharmaceutical design
01/01/2013
In vivo delivery of morpholino oligos by cell-penetrating peptides. (PubMedID: 23140456) Current pharmaceutical design
01/01/2013
CPP-conjugated anti-apoptotic peptides as therapeutic tools of ischemia-reperfusion injuries. (PubMedID: 23140457) Current pharmaceutical design
01/01/2013
Homeoproteins and homeoprotein-derived peptides: going in and out. (PubMedID: 23140458) Current pharmaceutical design
01/01/2013
Arginine-rich peptides: methods of translocation through biological membranes. (PubMedID: 23140459) Current pharmaceutical design
01/01/2013
PTD/CPP peptide-mediated delivery of siRNAs. (PubMedID: 23140460) Current pharmaceutical design
01/01/2013
Editorial: Cell penetrating peptides as delivery vectors for biomolecules. (PubMedID: 23140461) Current pharmaceutical design
01/01/2013
Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy. (PubMedID: 23151129) Current pharmaceutical design
01/01/2013
Deubiquitinating enzymes as promising drug targets for infectious diseases. (PubMedID: 23151130) Current pharmaceutical design
01/01/2013
Emerging role of the ubiquitin-proteasome system as drug targets. (PubMedID: 23151131) Current pharmaceutical design
01/01/2013
Comprehensive profiling of protein ubiquitination for drug discovery. (PubMedID: 23151132) Current pharmaceutical design
01/01/2013
Proteasome inhibition in transplantation-focusing on the experience with bortezomib. (PubMedID: 23151133) Current pharmaceutical design
01/01/2013
Dissecting bortezomib: development, application, adverse effects and future direction. (PubMedID: 23151134) Current pharmaceutical design
01/01/2013
Targeting the ubiquitin E1 as a novel anti-cancer strategy. (PubMedID: 23151135) Current pharmaceutical design
01/01/2013
Regulation of skeletal muscle plasticity by glycogen synthase kinase-3ß: a potential target for the treatment of muscle wasting. (PubMedID: 23151136) Current pharmaceutical design
01/01/2013
Cullin-RING Ligases as attractive anti-cancer targets. (PubMedID: 23151137) Current pharmaceutical design
01/01/2013
The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases. (PubMedID: 23151138) Current pharmaceutical design
01/01/2013
Cdc20: a potential novel therapeutic target for cancer treatment. (PubMedID: 23151139) Current pharmaceutical design
01/01/2013
When ubiquitin meets NF-?B: a trove for anti-cancer drug development. (PubMedID: 23151140) Current pharmaceutical design
01/01/2013
Pharmaceutical perspectives of HECT-type ubiquitin ligase Smurf1. (PubMedID: 23151141) Current pharmaceutical design
01/01/2013
Targeting the ubiquitin-proteasome pathway--current perspectives and future directions. (PubMedID: 23151142) Current pharmaceutical design
01/01/2013
The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. (PubMedID: 23151182) Current pharmaceutical design
01/01/2013
Effect of fibrin-binding synthetic oligopeptide on the healing of full-thickness skin wounds in streptozotocin-induced diabetic rats. (PubMedID: 23151183) Current pharmaceutical design
01/01/2013
The role of protonation states in ligand-receptor recognition and binding. (PubMedID: 23170880) Current pharmaceutical design
01/01/2013
Resolving differences in substrate specificities between human and parasite phosphoribosyltransferases via analysis of functional groups of substrates and receptors. (PubMedID: 23170881) Current pharmaceutical design
01/01/2013
Rigorous incorporation of tautomers, ionization species, and different binding modes into ligand-based and receptor-based 3D-QSAR methods. (PubMedID: 23170882) Current pharmaceutical design
01/01/2013
Potential application of network descriptions for understanding conformational changes and protonation states of ABC transporters. (PubMedID: 23170883) Current pharmaceutical design
01/01/2013
Protonation states and conformational ensemble in ligand-based QSAR modeling. (PubMedID: 23170884) Current pharmaceutical design
01/01/2013
Nucleotide binding affects intrinsic dynamics and structural communication in Ras GTPases. (PubMedID: 23170885) Current pharmaceutical design
01/01/2013
Effects of the protonation state of the catalytic residues and ligands upon binding and recognition in targeted proteins of HIV-1 and influenza viruses. (PubMedID: 23170886) Current pharmaceutical design
01/01/2013
Calculation methods for the enhancement of pharmaceutical properties in small molecules: estimating the cationic pKa. (PubMedID: 23170887) Current pharmaceutical design
01/01/2013
Correct protonation states and relevant waters = better computational simulations? (PubMedID: 23170888) Current pharmaceutical design
01/01/2013
Protonation States in molecular dynamics simulations of peptide folding and binding. (PubMedID: 23170889) Current pharmaceutical design
01/01/2013
Protein: ligand recognition: simple models for electrostatic effects. (PubMedID: 23170890) Current pharmaceutical design
01/01/2013
On the active site protonation state in aspartic proteases: implications for drug design. (PubMedID: 23170891) Current pharmaceutical design
01/01/2013
Intrinsic disorder-based protein interactions and their modulators. (PubMedID: 23170892) Current pharmaceutical design
01/01/2013
Protonation states and conformational dynamics in ligand-target recognition and binding. (PubMedID: 23170893) Current pharmaceutical design
01/01/2013
Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression. (PubMedID: 23173582) Current pharmaceutical design
01/01/2013
Molecular markers of cardiovascular damage in hypertension. (PubMedID: 23173583) Current pharmaceutical design
01/01/2013
Effect of aging on metabolic pathways in endothelial progenitor cells. (PubMedID: 23173584) Current pharmaceutical design
01/01/2013
Microvascular function/dysfunction downstream a coronary stenosis. (PubMedID: 23173585) Current pharmaceutical design
01/01/2013
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state. (PubMedID: 23173586) Current pharmaceutical design
01/01/2013
Microvascular endothelial dysfunction in obesity and hypertension. (PubMedID: 23173587) Current pharmaceutical design
01/01/2013
Functional and structural alterations of large arteries: methodological issues. (PubMedID: 23173588) Current pharmaceutical design
01/01/2013
Device-based therapies for resistant hypertension. (PubMedID: 23173589) Current pharmaceutical design
01/01/2013
Sleep loss and hypertension: a systematic review. (PubMedID: 23173590) Current pharmaceutical design
01/01/2013
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk. (PubMedID: 23173591) Current pharmaceutical design
01/01/2013
Chronic hyperuricemia, uric acid deposit and cardiovascular risk. (PubMedID: 23173592) Current pharmaceutical design
01/01/2013
Cardiovascular molecular imaging: new methodological strategies. (PubMedID: 23173593) Current pharmaceutical design
01/01/2013
The economic costs for the control of cardiovascular risk: an overview. (PubMedID: 23173594) Current pharmaceutical design
01/01/2013
Modifying cardiovascular risk factors: new markers of cardiovascular damage. (PubMedID: 23173595) Current pharmaceutical design
01/01/2013
Recent progress in molecular mechanisms of angiotensin II type 1 and 2 receptors. (PubMedID: 23176209) Current pharmaceutical design
01/01/2013
Angiotensin II type 1 and type 2 receptor-induced cell signaling. (PubMedID: 23176210) Current pharmaceutical design
01/01/2013
Gene polymorphism of angiotensin II type 1 and type 2 receptors. (PubMedID: 23176211) Current pharmaceutical design
01/01/2013
Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers. (PubMedID: 23176212) Current pharmaceutical design
01/01/2013
The pharmacological effects of novokinin; a designed peptide agonist of the angiotensin AT2 receptor. (PubMedID: 23176213) Current pharmaceutical design
01/01/2013
Regulation of angiotensin II receptor expression. (PubMedID: 23176214) Current pharmaceutical design
01/01/2013
Redox control of cardiovascular homeostasis by angiotensin II. (PubMedID: 23176215) Current pharmaceutical design
01/01/2013
Angiotensin II blockade and renal protection. (PubMedID: 23176216) Current pharmaceutical design
01/01/2013
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. (PubMedID: 23176217) Current pharmaceutical design
01/01/2013
Potential effect of angiotensin II receptor blockade in adipose tissue and bone. (PubMedID: 23176218) Current pharmaceutical design
01/01/2013
Non-ACE pathway-induced angiotensin II production. (PubMedID: 23176219) Current pharmaceutical design
01/01/2013
Angiotensin (1-7) and other angiotensin peptides. (PubMedID: 23176220) Current pharmaceutical design
01/01/2013
Chymase inhibitors. (PubMedID: 23176221) Current pharmaceutical design
01/01/2013
Angiotensin II receptor research. (PubMedID: 23176222) Current pharmaceutical design
01/01/2013
Deubiquitinating enzymes as therapeutic targets in cancer. (PubMedID: 23181570) Current pharmaceutical design
01/01/2013
Drug combinations with proteasome inhibitors in antitumor therapy. (PubMedID: 23181571) Current pharmaceutical design
01/01/2013
From Bortezomib to other Inhibitors of the proteasome and beyond. (PubMedID: 23181572) Current pharmaceutical design
01/01/2013
Non-covalent proteasome inhibitors. (PubMedID: 23181573) Current pharmaceutical design
01/01/2013
Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy. (PubMedID: 23181574) Current pharmaceutical design
01/01/2013
Targeting the ubiquitin proteasome system: beyond proteasome inhibition. (PubMedID: 23181575) Current pharmaceutical design
01/01/2013
Inhibitors of the immunoproteasome: current status and future directions. (PubMedID: 23181576) Current pharmaceutical design
01/01/2013
Editorial (the ubiquitin proteasome system as a source of drug targets for cancer therapy). (PubMedID: 23181577) Current pharmaceutical design
01/01/2013
Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: focus on the glycine transporter 1 (GlyT1). (PubMedID: 23194655) Current pharmaceutical design
01/01/2013
Levosimendan preoperative. (PubMedID: 23228313) Current pharmaceutical design
01/01/2013
Pharmacologic treatment of pulmonary arterial hypertension. (PubMedID: 23228314) Current pharmaceutical design
01/01/2013
Perioperative B-blockers in Non-cardiac Surgery: Actual Situation. (PubMedID: 23228315) Current pharmaceutical design
01/01/2013
Pharmacologic Methods to Reduce Postoperative Bleeding in Adult Cardiac Surgery. A Mini-review. (PubMedID: 23228316) Current pharmaceutical design
01/01/2013
Corticosteroids for the inflammatory response to cardiopulmonary bypass: an update. (PubMedID: 23228317) Current pharmaceutical design
01/01/2013
Sevoflurane in intraoperative and postoperative cardiac surgery patients. Our experience in intensive care unit with sevoflurane sedation. (PubMedID: 23228318) Current pharmaceutical design
01/01/2013
Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit. (PubMedID: 23228319) Current pharmaceutical design
01/01/2013
Clopidogrel, aspirin and proton pump inhibition after percutaneous valve implants: an update. (PubMedID: 23228320) Current pharmaceutical design
01/01/2013
Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis. (PubMedID: 23228321) Current pharmaceutical design
01/01/2013
Editorial (hot topic:current situation at perioperative of cardiovascular disease patients: new addressing and perioperative optimization techniques). (PubMedID: 23228322) Current pharmaceutical design
01/01/2013
Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers. (PubMedID: 23237054) Current pharmaceutical design
01/01/2013
Therapy against reperfusion-induced microvascular injury. (PubMedID: 23270550) Current pharmaceutical design
01/01/2013
Therapy against ischemic injury. (PubMedID: 23270551) Current pharmaceutical design
01/01/2013
Mechanisms, prevention and treatment of distal embolization. (PubMedID: 23270552) Current pharmaceutical design
01/01/2013
No-reflow: incidence and detection in the cath-lab. (PubMedID: 23270553) Current pharmaceutical design
01/01/2013
Cardioprotection techniques: preconditioning, postconditioning and remote con-ditioning (basic science). (PubMedID: 23270554) Current pharmaceutical design
01/01/2013
Protecting the heart: biological targets and clinical strategies. (PubMedID: 23270555) Current pharmaceutical design
01/01/2013
Modulation of individual susceptibility to the no-reflow phenomenon after acute myocardial infarction. (PubMedID: 23270556) Current pharmaceutical design
01/01/2013
No reflow: what's in a name? (PubMedID: 23270557) Current pharmaceutical design
01/01/2013
Advancement of targeted ultrasound contrast agents and their applications in molecular imaging and targeted therapy. (PubMedID: 23270592) Current pharmaceutical design
01/01/2013
Pioglitazone and cancer: angel or demon? (PubMedID: 23278487) Current pharmaceutical design
01/01/2013
Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? (PubMedID: 23278488) Current pharmaceutical design
01/01/2013
A review of the cardiovascular and anti-atherogenic effects of ghrelin. (PubMedID: 23278489) Current pharmaceutical design
01/01/2013
Novel approaches to the pharmacotherapy of obesity. (PubMedID: 23278490) Current pharmaceutical design
01/01/2013
Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance. (PubMedID: 23278491) Current pharmaceutical design
01/01/2013
Modern treatment of infection and ischaemia to reduce major amputation in the diabetic foot. (PubMedID: 23278492) Current pharmaceutical design
01/01/2013
Uric acid and diabetes: is there a link? (PubMedID: 23278493) Current pharmaceutical design
01/01/2013
Current options and perspectives in the treatment of diabetic neuropathy. (PubMedID: 23278494) Current pharmaceutical design
01/01/2013
Diabetes, obesity and vascular disease--an update. (PubMedID: 23278495) Current pharmaceutical design
01/01/2013
Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis. (PubMedID: 23278532) Current pharmaceutical design
01/01/2013
New insights into invasive aspergillosis--from the pathogen to the disease. (PubMedID: 23278533) Current pharmaceutical design
01/01/2013
Aspergillus--classification and antifungal susceptibilities. (PubMedID: 23278534) Current pharmaceutical design
01/01/2013
Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. (PubMedID: 23278535) Current pharmaceutical design
01/01/2013
Transcriptomic insights into the oxidative response of stress-exposed Aspergillus fumigatus. (PubMedID: 23278536) Current pharmaceutical design
01/01/2013
Invasive aspergillosis in children and adolescents. (PubMedID: 23278537) Current pharmaceutical design
01/01/2013
Invasive aspergillosis: new insights into disease, diagnostic and treatment. (PubMedID: 23278538) Current pharmaceutical design
01/01/2013
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis. (PubMedID: 23278539) Current pharmaceutical design
01/01/2013
Up-date on diagnostic strategies of invasive aspergillosis. (PubMedID: 23278540) Current pharmaceutical design
01/01/2013
Immunotherapy in invasive fungal infection--focus on invasive aspergillosis. (PubMedID: 23278541) Current pharmaceutical design
01/01/2013
Undressing the fungal cell wall/cell membrane--the antifungal drug targets. (PubMedID: 23278542) Current pharmaceutical design
01/01/2013
Aspergillosis: new insights into disease, diagnostic and treatment. (PubMedID: 23278543) Current pharmaceutical design
01/01/2013
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy. (PubMedID: 23278600) Current pharmaceutical design
01/01/2013
Recent progress on the applications of multifunctional glyconanoparticles. (PubMedID: 23278732) Current pharmaceutical design
01/01/2013
Anticoagulant prevention in patients with atrial fibrillation: alternatives to vitamin K antagonists. (PubMedID: 23286429) Current pharmaceutical design
01/01/2013
Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality. (PubMedID: 23286430) Current pharmaceutical design
01/01/2013
Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker? (PubMedID: 23286431) Current pharmaceutical design
01/01/2013
Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring. (PubMedID: 23286432) Current pharmaceutical design
01/01/2013
Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension. (PubMedID: 23286433) Current pharmaceutical design
01/01/2013
Metabolic syndrome and cardiovascular health: a look beyond the horizon. (PubMedID: 23844872) Current pharmaceutical design
01/01/2013
Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus. (PubMedID: 23768444) Current pharmaceutical design
01/01/2013
Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: New Insight in Selection of Rhythm or Rate Control Therapy and Impact of Mean Platelet Volume. (PubMedID: 23713815) Current pharmaceutical design
01/01/2013
The biology of the peroxisome proliferator-activated receptor system in the female reproductive tract. (PubMedID: 23565653) Current pharmaceutical design
01/01/2013
MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. (PubMedID: 23570052) Current pharmaceutical design
01/01/2013
Immune system, cell senescence, aging and longevity--inflamm-aging reappraised. (PubMedID: 23589904) Current pharmaceutical design
01/01/2013
Targets for Anti-metastatic Drug Development. (PubMedID: 23607665) Current pharmaceutical design
01/01/2013
Novel Insights into Biased Agonism at G Protein-Coupled Receptors and their Potential for Drug Design. (PubMedID: 23621547) Current pharmaceutical design
01/01/2013
Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction. (PubMedID: 23621548) Current pharmaceutical design
01/01/2013
New strategy for high throughput screening of anti-influenza virus m2 ion channel inhibitors. (PubMedID: 23621591) Current pharmaceutical design
01/01/2013
Factors affecting residual platelet aggregation in prasugrel treated patients. (PubMedID: 23651444) Current pharmaceutical design
01/01/2013
[Antiviral activities of ISG20 against hepatitis C virus]. (PubMedID: 23663760) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Screening and identification of HLA-A0201 restricted cytotoxic T lymphocyte epitopes from hepatitis B virus E antigen in vitro]. (PubMedID: 23663761) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice]. (PubMedID: 23663762) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Expression and correlation of angiotensin-converting enzyme 2 in CCl4-induced rat liver fibrosis]. (PubMedID: 23663763) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Preparation and in vitro study of a high molecular weight contrast agent targeting hepatoma cells]. (PubMedID: 23663764) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Significance of high sensitivity C-reactive protein level for predicting risk of nonalcoholic fatty liver in type 2 diabetes mellitus patients]. (PubMedID: 23663765) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Risk factors analysis of nonalcoholic fatty liver disease in Chinese men]. (PubMedID: 23663766) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[Effects of quercetin on serum levels of resistin and IL-18 and on insulin resistance in nonalcoholic fatty liver disease rats]. (PubMedID: 23663767) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
Maturation of corpus callosum anterior midbody is associated with neonatal motor function in eight preterm-born infants. (PubMedID: 23509639) Neural plasticity
01/01/2013
Axon guidance mechanisms for establishment of callosal connections. (PubMedID: 23533817) Neural plasticity
01/01/2013
Influence of inflammation on poststroke plasticity. (PubMedID: 23533818) Neural plasticity
01/01/2013
Time of day does not modulate improvements in motor performance following a repetitive ballistic motor training task. (PubMedID: 23577271) Neural plasticity
01/01/2013
Different current intensities of anodal transcranial direct current stimulation do not differentially modulate motor cortex plasticity. (PubMedID: 23577272) Neural plasticity
01/01/2013
Splenium of corpus callosum: patterns of interhemispheric interaction in children and adults. (PubMedID: 23577273) Neural plasticity
01/01/2013
Quality and timing of stressors differentially impact on brain plasticity and neuroendocrine-immune function in mice. (PubMedID: 23606988) Neural plasticity
01/01/2013
The visual callosal connection: a connection like any other? (PubMedID: 23634306) Neural plasticity
01/01/2013
Neurogenesis, exercise, and cognitive late effects of pediatric radiotherapy. (PubMedID: 23691370) Neural plasticity
01/01/2013
The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. (PubMedID: 23691371) Neural plasticity
01/01/2013
Influence of osmotic shock on Escherichia coli insoluble protein fraction in the presence of exogenous osmolytes. (PubMedID: 23594427) Journal of molecular microbiology and biotechnology
01/01/2013
Crucial roles of MicA and RybB as vital factors for s-dependent cell lysis in Escherichia coli long-term stationary phase. (PubMedID: 23594456) Journal of molecular microbiology and biotechnology
01/01/2013
Effect of linoleic acids on the release of ß-carotene from carotenoid-producing Saccharomyces cerevisiae into sunflower oil. (PubMedID: 23594478) Journal of molecular microbiology and biotechnology
01/01/2013
Cloning, overexpression, and functional characterization of a phytase from the genus bacillus. (PubMedID: 23594993) Journal of molecular microbiology and biotechnology
01/01/2013
Simple method to differentiate among Rickettsia species. (PubMedID: 23595041) Journal of molecular microbiology and biotechnology
01/01/2013
The Tat pathway is prevalent in Listeria monocytogenes lineage II and is not required for infection and spread in host cells. (PubMedID: 23595063) Journal of molecular microbiology and biotechnology
01/01/2013
Membranous organelles in bacteria. (PubMedID: 23615191) Journal of molecular microbiology and biotechnology
01/01/2013
Membrane invaginations in bacteria and mitochondria: common features and evolutionary scenarios. (PubMedID: 23615192) Journal of molecular microbiology and biotechnology
01/01/2013
Subcellular localization and logistics of integral membrane protein biogenesis in Escherichia coli. (PubMedID: 23615193) Journal of molecular microbiology and biotechnology
01/01/2013
The intracytoplasmic membranes of purple bacteria--assembly of energy-transducing complexes. (PubMedID: 23615194) Journal of molecular microbiology and biotechnology
01/01/2013
Structural and functional proteomics of intracytoplasmic membrane assembly in Rhodobacter sphaeroides. (PubMedID: 23615195) Journal of molecular microbiology and biotechnology
01/01/2013
The bacterial magnetosome: a unique prokaryotic organelle. (PubMedID: 23615196) Journal of molecular microbiology and biotechnology
01/01/2013
Magnetosomes: how do they stay in shape? (PubMedID: 23615197) Journal of molecular microbiology and biotechnology
01/01/2013
Nested bacterial boxes: nuclear and other intracellular compartments in planctomycetes. (PubMedID: 23615198) Journal of molecular microbiology and biotechnology
01/01/2013
The anammoxosome organelle is crucial for the energy metabolism of anaerobic ammonium oxidizing bacteria. (PubMedID: 23615199) Journal of molecular microbiology and biotechnology
01/01/2013
Bacterial outer membrane vesicles in trafficking, communication and the host-pathogen interaction. (PubMedID: 23615200) Journal of molecular microbiology and biotechnology
01/01/2013
Functional advantages conferred by extracellular prokaryotic membrane vesicles. (PubMedID: 23615201) Journal of molecular microbiology and biotechnology
01/01/2013
The role of membrane vesicles in secretion of Lysobacter sp. bacteriolytic enzymes. (PubMedID: 23615202) Journal of molecular microbiology and biotechnology
01/01/2013
The coevolutionary roots of biochemistry and cellular organization challenge the RNA world paradigm. (PubMedID: 23615203) Journal of molecular microbiology and biotechnology
01/01/2013
Phylogenomics supports a cellularly structured urancestor. (PubMedID: 23615204) Journal of molecular microbiology and biotechnology
01/01/2013
A rational approach to identify inhibitors of Mycobacterium tuberculosis enoyl acyl carrier protein reductase. (PubMedID: 23477735) Current pharmaceutical design
01/01/2013
Molecular modeling and QSAR studies for drug design. (PubMedID: 23489161) Current pharmaceutical design
01/01/2013
Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis. (PubMedID: 23476809) Neural plasticity
01/01/2013
Functional topography of human corpus callosum: an FMRI mapping study. (PubMedID: 23476810) Neural plasticity
01/01/2013
Why I am not shy: a reply to Tononi and Cirelli. (PubMedID: 23476811) Neural plasticity
01/01/2013
Acute ischemic cerebrovascular events on antiplatelet therapy: what is the optimal prevention strategy? (PubMedID: 23286434) Current pharmaceutical design
01/01/2013
PCSK9 inhibition - a novel mechanism to treat lipid disorders? (PubMedID: 23286435) Current pharmaceutical design
01/01/2013
Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia? (PubMedID: 23286436) Current pharmaceutical design
01/01/2013
Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives. (PubMedID: 23286437) Current pharmaceutical design
01/01/2013
How should we treat hypertension and dyslipidemia in patients with prediabetes? (PubMedID: 23286438) Current pharmaceutical design
01/01/2013
Achieving current goals in prevention and treatment of vascular disease: an update. (PubMedID: 23286439) Current pharmaceutical design
01/01/2013
Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin. (PubMedID: 23305268) Current pharmaceutical design
01/01/2013
The role of fibrate treatment in dyslipidemia: an overview. (PubMedID: 23317397) Current pharmaceutical design
01/01/2013
Ezetimibe therapy for dyslipidemia: an update. (PubMedID: 23317398) Current pharmaceutical design
01/01/2013
The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease. (PubMedID: 23317399) Current pharmaceutical design
01/01/2013
The role of niacin in lipid-lowering treatment: are we aiming too high? (PubMedID: 23317400) Current pharmaceutical design
01/01/2013
Apolipoprotein B antisense inhibition--update on mipomersen. (PubMedID: 23317401) Current pharmaceutical design
01/01/2013
Colesevelam: a new and improved bile acid sequestrant? (PubMedID: 23317402) Current pharmaceutical design
01/01/2013
Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias. (PubMedID: 23317403) Current pharmaceutical design
01/01/2013
Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors in the treatment of hypercholesterolemia and other pathologies. (PubMedID: 23317404) Current pharmaceutical design
01/01/2013
Omega-3 fatty acids: role in metabolism and cardiovascular disease. (PubMedID: 23317405) Current pharmaceutical design
01/01/2013
Current and future options for lipid-lowering therapy beyond statins. (PubMedID: 23317406) Current pharmaceutical design
01/01/2013
Glucocorticoid excess induces accumulation of cardiac glycogen and triglyceride: suggested role for AMPK. (PubMedID: 23323614) Current pharmaceutical design
01/01/2013
Functions of the third intracellular loop of the human melanocortin-3 receptor. (PubMedID: 23323615) Current pharmaceutical design
01/01/2013
Cardiac stem cell regeneration in metabolic syndrome. (PubMedID: 23323616) Current pharmaceutical design
01/01/2013
PPAR? activation improves the molecular and functional components of I to remodeling by angiotensin II. (PubMedID: 23323617) Current pharmaceutical design
01/01/2013
Searching for phytoinsulins as cardiovascular protector in metabolic syndrome. (PubMedID: 23323618) Current pharmaceutical design
01/01/2013
Modulation of staurosporine-activated volume-sensitive outwardly rectifying Cl- channel by PI3K/Akt in cardiomyocytes. (PubMedID: 23323619) Current pharmaceutical design
01/01/2013
MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2. (PubMedID: 23323620) Current pharmaceutical design
01/01/2013
Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. (PubMedID: 23323621) Current pharmaceutical design
01/01/2013
Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. (PubMedID: 23323622) Current pharmaceutical design
01/01/2013
F508del-CFTR rescue: a matter of cell stress response. (PubMedID: 23331026) Current pharmaceutical design
01/01/2013
Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis. (PubMedID: 23331027) Current pharmaceutical design
01/01/2013
Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis. (PubMedID: 23331028) Current pharmaceutical design
01/01/2013
Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications. (PubMedID: 23331029) Current pharmaceutical design
01/01/2013
CFTR inhibitors. (PubMedID: 23331030) Current pharmaceutical design
01/01/2013
Cystic fibrosis: CFTR modulators and their mechanism of action. (PubMedID: 23331031) Current pharmaceutical design
01/01/2013
Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT. (PubMedID: 23339739) Current pharmaceutical design
01/01/2013
Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies. (PubMedID: 23343120) Current pharmaceutical design
01/01/2013
Recent advances of diaryl ether family as HIV-1 non-nucleoside reverse transcriptase inhibitors. (PubMedID: 23343121) Current pharmaceutical design
01/01/2013
Cytochrome P450 2C19 polymorphism and antiplatelet therapy. Who should really be genotyped? (PubMedID: 23360266) Current pharmaceutical design
01/01/2013
Role of descending aminergic pathways in the development of locomotion. (PubMedID: 23360267) Current pharmaceutical design
01/01/2013
The control of male sexual responses. (PubMedID: 23360268) Current pharmaceutical design
01/01/2013
Control and role of plateau potential properties in the spinal cord. (PubMedID: 23360269) Current pharmaceutical design
01/01/2013
Modulation of the intrinsic properties of motoneurons by serotonin. (PubMedID: 23360270) Current pharmaceutical design
01/01/2013
How do glial cells contribute to motor control? (PubMedID: 23360271) Current pharmaceutical design
01/01/2013
Rho as a target to promote repair: translation to clinical studies with cethrin. (PubMedID: 23360272) Current pharmaceutical design
01/01/2013
Neuropeptide/Receptor expression and plasticity in micturition pathways. (PubMedID: 23360273) Current pharmaceutical design
01/01/2013
Pharmacological approaches to chronic spinal cord injury. (PubMedID: 23360274) Current pharmaceutical design
01/01/2013
A valuable animal model of spinal cord injury to study motor dysfunctions, comorbid conditions, and aging associated diseases. (PubMedID: 23360275) Current pharmaceutical design
01/01/2013
The multifunctional mesencephalic locomotor region. (PubMedID: 23360276) Current pharmaceutical design
01/01/2013
Sex, stress and their influence on respiratory regulation. (PubMedID: 23360277) Current pharmaceutical design
01/01/2013
Extrasynaptic GABA(A) receptors in the brainstem and spinal cord: structure and function. (PubMedID: 23360278) Current pharmaceutical design
01/01/2013
Activity-dependent synaptic plasticity and metaplasticity in spinal motor networks. (PubMedID: 23360279) Current pharmaceutical design
01/01/2013
Role of neurotrophins in spinal plasticity and locomotion. (PubMedID: 23360280) Current pharmaceutical design
01/01/2013
Pharmacology and biochemistry of stereotyped motor behaviors. (PubMedID: 23360281) Current pharmaceutical design
01/01/2013
Recent developments of DNA poisons--human DNA topoisomerase IIa inhibitors--as anticancer agents. (PubMedID: 23363399) Current pharmaceutical design
01/01/2013
Molecular chaperone ORP150 in ER stress-related diseases. (PubMedID: 23363441) Current pharmaceutical design
01/01/2013
Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer. (PubMedID: 23363442) Current pharmaceutical design
01/01/2013
Anticancer Therapeutic Strategies Based on CDK Inhibitors. (PubMedID: 23394082) Current pharmaceutical design
01/01/2013
New Molecular Targets in the Treatment of NSCLC. (PubMedID: 23394083) Current pharmaceutical design
01/01/2013
Resveratrol and cancer treatment: is hormesis a yet unsolved matter? (PubMedID: 23394084) Current pharmaceutical design
01/01/2013
Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis. (PubMedID: 23394085) Current pharmaceutical design
01/01/2013
How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments. (PubMedID: 23394086) Current pharmaceutical design
01/01/2013
The culture-repopulating ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells. (PubMedID: 23394087) Current pharmaceutical design
01/01/2013
Inorganic phosphate as a signaling molecule: a potential strategy in osteosarcoma treatment. (PubMedID: 23394088) Current pharmaceutical design
01/01/2013
Editorial (naturally occurring molecules and anticancer combination therapies in the era of personalized medicine and economic crisis). (PubMedID: 23394089) Current pharmaceutical design
01/01/2013
Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease. (PubMedID: 23394090) Current pharmaceutical design
01/01/2013
Epidemiology and Natural History of Patients with NAFLD. (PubMedID: 23394091) Current pharmaceutical design
01/01/2013
Pathophysiology of NASH: Perspectives for a Targeted Treatment. (PubMedID: 23394092) Current pharmaceutical design
01/01/2013
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. (PubMedID: 23394093) Current pharmaceutical design
01/01/2013
Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients? (PubMedID: 23394094) Current pharmaceutical design
01/01/2013
The Role of Lifestyle Change in the Prevention and Treatment of NAFLD. (PubMedID: 23394095) Current pharmaceutical design
01/01/2013
Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD. (PubMedID: 23394096) Current pharmaceutical design
01/01/2013
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment. (PubMedID: 23394097) Current pharmaceutical design
01/01/2013
Editorial (Hot Topic: Update on Treatment Strategies in Patients with Non-alcoholic Fatty Liver Disease). (PubMedID: 23394098) Current pharmaceutical design
01/01/2013
Metabolic engineering of plant secondary products: which way forward? (PubMedID: 23394556) Current pharmaceutical design
01/01/2013
Developing country applications of molecular farming: case studies in South Africa and Argentina. (PubMedID: 23394557) Current pharmaceutical design
01/01/2013
Expression and characterisation of recombinant molecules in transgenic soybean. (PubMedID: 23394558) Current pharmaceutical design
01/01/2013
The Use of Transient Expression Systems for the Rapid Production of Virus-like Particles in Plants. (PubMedID: 23394559) Current pharmaceutical design
01/01/2013
Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues. (PubMedID: 23394560) Current pharmaceutical design
01/01/2013
Plant cells as pharmaceutical factories. (PubMedID: 23394561) Current pharmaceutical design
01/01/2013
N-Glycosylation of Plant-produced Recombinant Proteins. (PubMedID: 23394562) Current pharmaceutical design
01/01/2013
Target product selection - where can molecular pharming make the difference? (PubMedID: 23394563) Current pharmaceutical design
01/01/2013
Immunogenicity and Protective Efficacy of Candidate Universal Influenza A Nanovaccines Produced in Plants by Tobacco Mosaic Virus-based Vectors. (PubMedID: 23394564) Current pharmaceutical design
01/01/2013
Risk Assessment and Regulation of Molecular Farming - A Comparison between Europe and US. (PubMedID: 23394565) Current pharmaceutical design
01/01/2013
Commercial aspects of pharmaceutical protein production in plants. (PubMedID: 23394566) Current pharmaceutical design
01/01/2013
Optimizing the yield of recombinant pharmaceutical proteins in plants. (PubMedID: 23394567) Current pharmaceutical design
01/01/2013
Seeds as a production system for molecular pharming applications: status and prospects. (PubMedID: 23394568) Current pharmaceutical design
01/01/2013
Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. (PubMedID: 23394569) Current pharmaceutical design
01/01/2013
Veterinary vaccines from transgenic plants: highlights of two decades of research and a promising example. (PubMedID: 23394570) Current pharmaceutical design
01/01/2013
Hybrid viral vectors for vaccine and antibody production in plants. (PubMedID: 23394571) Current pharmaceutical design
01/01/2013
Editorial (hot topic: from medicinal plants to medicines in plants: plant factories for the production of valuable pharmaceuticals). (PubMedID: 23394572) Current pharmaceutical design
01/01/2013
SNAP-Tag Technology: A General Introduction. (PubMedID: 23431982) Current pharmaceutical design
01/01/2013
Substrates for Improved Live-Cell Fluorescence Labeling of SNAP-tag. (PubMedID: 23431983) Current pharmaceutical design
01/01/2013
SNAP Display - an In Vitro Method for the Selection of Protein Binders. (PubMedID: 23431984) Current pharmaceutical design
01/01/2013
SNAP-tag based Agents for Preclinical In Vitro Imaging in Malignant Diseases. (PubMedID: 23431985) Current pharmaceutical design
01/01/2013
SNAP-Tag Technology: A Powerful Tool for Site Specific Conjugation of Therapeutic and Imaging Agents. (PubMedID: 23431986) Current pharmaceutical design
01/01/2013
SNAP-tag as a Tool for Surface Immobilization. (PubMedID: 23431987) Current pharmaceutical design
01/01/2013
The Role of SNAP-tag in Technical Approaches. (PubMedID: 23431988) Current pharmaceutical design
01/01/2013
Fluorescent SNAP-Tag Galectin Fusion Proteins as Novel Tools in Glycobiology. (PubMedID: 23431989) Current pharmaceutical design
01/01/2013
Editorial (The SNAP-tag Technology - A Versatile Tool with many Applications). (PubMedID: 23431990) Current pharmaceutical design
01/01/2013
An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting. (PubMedID: 23431995) Current pharmaceutical design
01/01/2013
Targeting cytokines: production and characterization of anti-TNF-a scFvs by phage display technology. (PubMedID: 23432628) Current pharmaceutical design
01/01/2013
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD. (PubMedID: 23432668) Current pharmaceutical design
01/01/2013
Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target. (PubMedID: 23432669) Current pharmaceutical design
01/01/2013
Regulation of angiogenesis and bone regeneration with natural and synthetic small molecules. (PubMedID: 23432670) Current pharmaceutical design
01/01/2013
Strategies to direct angiogenesis within scaffolds for bone tissue engineering. (PubMedID: 23432671) Current pharmaceutical design
01/01/2013
Osteogenic peptides in bone regeneration. (PubMedID: 23432672) Current pharmaceutical design
01/01/2013
The role of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in orthopaedic bone repair and regeneration. (PubMedID: 23432673) Current pharmaceutical design
01/01/2013
Gene therapy for bone regeneration. (PubMedID: 23432674) Current pharmaceutical design
01/01/2013
Osteoinductive biomaterial geometries for bone regenerative engineering. (PubMedID: 23432675) Current pharmaceutical design
01/01/2013
Fibroblast growth factor-2, bone homeostasis and fracture repair. (PubMedID: 23432676) Current pharmaceutical design
01/01/2013
Combined angiogenic and osteogenic factor delivery for bone regenerative engineering. (PubMedID: 23432677) Current pharmaceutical design
01/01/2013
Osteoinductive small molecules: growth factor alternatives for bone tissue engineering. (PubMedID: 23432678) Current pharmaceutical design
01/01/2013
Stem cell-based tissue engineering approaches for musculoskeletal regeneration. (PubMedID: 23432679) Current pharmaceutical design
01/01/2013
Growth differentiation factor 5 regulation in bone regeneration. (PubMedID: 23432680) Current pharmaceutical design
01/01/2013
Bone morphogenetic proteins for bone regeneration and their alternatives. (PubMedID: 23432681) Current pharmaceutical design
01/01/2013
Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention. (PubMedID: 23438951) Current pharmaceutical design
01/01/2013
T Cell-based Therapies for Atherosclerosis. (PubMedID: 23438952) Current pharmaceutical design
01/01/2013
Taking risk prediction to the next level. Advances in biomarker research for atherosclerosis. (PubMedID: 23438953) Current pharmaceutical design
01/01/2013
Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions. (PubMedID: 23438954) Current pharmaceutical design
01/01/2013
Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications. (PubMedID: 23438955) Current pharmaceutical design
01/01/2013
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy. (PubMedID: 23438956) Current pharmaceutical design
01/01/2013
Potential use of dendritic cells for anti-atherosclerotic therapy. (PubMedID: 23438957) Current pharmaceutical design
01/01/2013
Emerging Anti-inflammatory Therapies for Atherosclerosis. (PubMedID: 23438958) Current pharmaceutical design
01/01/2013
Novel monocyte biomarkers of atherogenic conditions. (PubMedID: 23438959) Current pharmaceutical design
01/01/2013
Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet. (PubMedID: 23438960) Current pharmaceutical design
01/01/2013
Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis. (PubMedID: 23438961) Current pharmaceutical design
01/01/2013
Cyclophilins in atherosclerosis: a new therapeutic target? (PubMedID: 23438962) Current pharmaceutical design
01/01/2013
The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development. (PubMedID: 23438963) Current pharmaceutical design
01/01/2013
Dendritic cells in atherosclerosis. (PubMedID: 23438964) Current pharmaceutical design
01/01/2013
Editorial (Novel Targets and Biomarkers for Anti-atherosclerotic Therapy). (PubMedID: 23438965) Current pharmaceutical design
01/01/2013
Current developments of coumarin compounds in medicinal chemistry. (PubMedID: 23438968) Current pharmaceutical design
01/01/2013
Exploring molecular and clinical management of patients in the follow up of the HPV related uterine lesions. (PubMedID: 23445073) Current pharmaceutical design
01/01/2013
Anderson-fabry disease: a multiorgan disease. (PubMedID: 23448451) Current pharmaceutical design
01/01/2013
Neurological complications of anderson-fabry disease. (PubMedID: 23448452) Current pharmaceutical design
01/01/2013
Fabry disease and cardiovascular involvement. (PubMedID: 23448453) Current pharmaceutical design
01/01/2013
Cutaneous complications of anderson-fabry disease. (PubMedID: 23448454) Current pharmaceutical design
01/01/2013
Anderson-fabry disease in children. (PubMedID: 23448455) Current pharmaceutical design
01/01/2013
Renal complications of fabry disease. (PubMedID: 23448456) Current pharmaceutical design
01/01/2013
Gastroenterological complications of anderson-fabry disease. (PubMedID: 23448457) Current pharmaceutical design
01/01/2013
Editorial (anderson fabry disease: a multiorgan metabolic disease susceptible of treatment). (PubMedID: 23448458) Current pharmaceutical design
01/01/2013
Histone acetylation: from code to web and router via intrinsically disordered regions. (PubMedID: 23448459) Current pharmaceutical design
01/01/2013
Histone acetylation in neurodevelopment. (PubMedID: 23448460) Current pharmaceutical design
01/01/2013
Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders. (PubMedID: 23448461) Current pharmaceutical design
01/01/2013
Histone Post-translational Modifications to Target Memory-related Diseases. (PubMedID: 23448462) Current pharmaceutical design
01/01/2013
Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model. (PubMedID: 23448463) Current pharmaceutical design
01/01/2013
Histone Post-translational Modifications in Huntington's and Parkinson's Diseases. (PubMedID: 23448464) Current pharmaceutical design
01/01/2013
Histone acetylation as a potential therapeutic target in motor neuron degenerative diseases. (PubMedID: 23448465) Current pharmaceutical design
01/01/2013
Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery. (PubMedID: 23448466) Current pharmaceutical design
01/01/2013
Editorial (hot topic: targeting histone acetylation for neuroprotection). (PubMedID: 23448467) Current pharmaceutical design
01/01/2013
ULK1 plays a critical role in AMPK-mediated myocardial autophagy and contractile dysfunction following acute alcohol challenge. (PubMedID: 23448468) Current pharmaceutical design
01/01/2013
Targeted radiosensitization in prostate cancer. (PubMedID: 23448469) Current pharmaceutical design
01/01/2013
Structural, Biochemical and Non-Traditional Cardiovascular Risk Markers in PCOS. (PubMedID: 23448483) Current pharmaceutical design
01/01/2013
Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases. (PubMedID: 23448484) Current pharmaceutical design
01/01/2013
Why does obesity increase the risk for cardiovascular disease? (PubMedID: 23448485) Current pharmaceutical design
01/01/2013
Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. (PubMedID: 23448486) Current pharmaceutical design
01/01/2013
Mediators of Low-Grade Chronic Inflammation in Polycystic Ovary Syndrome (PCOS). (PubMedID: 23448487) Current pharmaceutical design
01/01/2013
Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application. (PubMedID: 23448488) Current pharmaceutical design
01/01/2013
MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases. (PubMedID: 23448489) Current pharmaceutical design
01/01/2013
Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins. (PubMedID: 23448490) Current pharmaceutical design
01/01/2013
Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target? (PubMedID: 23448491) Current pharmaceutical design
01/01/2013
Mitochondrial dysfunction and oxidative stress in insulin resistance. (PubMedID: 23448492) Current pharmaceutical design
01/01/2013
Endothelial dysfunction in morbid obesity. (PubMedID: 23448493) Current pharmaceutical design
01/01/2013
Editorial (hot topic: new insights into insulin resistance, cardiovascular diseases and oxidative stress: pathophysiological and clinical consequences). (PubMedID: 23448494) Current pharmaceutical design
01/01/2013
Ultrasound-based multimodal molecular imaging and functional ultrasound contrast agents. (PubMedID: 23448498) Current pharmaceutical design
01/01/2013
Editorial: cellular senescence and inflammation: advances and therapeutic targets in aging and major age-related diseases. (PubMedID: 23464627) Current pharmaceutical design
01/01/2013
Stimulation of perforant path fibers induces LTP concurrently in amygdala and hippocampus in awake freely behaving rats. (PubMedID: 23401801) Neural plasticity
01/01/2013
Treadmill exercise induces hippocampal astroglial alterations in rats. (PubMedID: 23401802) Neural plasticity
01/01/2013
Ubiquitination of neurotransmitter receptors and postsynaptic scaffolding proteins. (PubMedID: 23431475) Neural plasticity
01/01/2013
The impact of community organization on vector-borne pathogens. (PubMedID: 23234841) The American naturalist
01/01/2013
Pathogen diversity and hidden regimes of apparent competition. (PubMedID: 23234842) The American naturalist
01/01/2013
Experimental evidence for density-dependent regulation and selection on Trinidadian guppy life histories. (PubMedID: 23234843) The American naturalist
01/01/2013
Complex life cycles: why refrain from growth before reproduction in the adult niche? (PubMedID: 23234844) The American naturalist
01/01/2013
Evolution of diadromy in fish: insights from a tropical genus (Kuhlia species). (PubMedID: 23234845) The American naturalist
01/01/2013
Optimal control in individual-based models: implications from aggregated methods. (PubMedID: 23234846) The American naturalist
01/01/2013
Predation's role in life-history evolution of a livebearing fish and a test of the Trexler-DeAngelis model of maternal provisioning. (PubMedID: 23234847) The American naturalist
01/01/2013
Iterative ecological radiation and convergence during the evolutionary history of damselfishes (Pomacentridae). (PubMedID: 23234848) The American naturalist
01/01/2013
Migration or residency? The evolution of movement behavior and information usage in seasonal environments. (PubMedID: 23234849) The American naturalist
01/01/2013
Within-clutch variation in yolk testosterone as an adaptive maternal effect to modulate avian sibling competition: evidence from a comparative study. (PubMedID: 23234850) The American naturalist
01/01/2013
Insectivorous bat pollinates columnar cactus more effectively per visit than specialized nectar bat. (PubMedID: 23234851) The American naturalist
01/01/2013
Avian predation pressure as a potential driver of periodical cicada cycle length. (PubMedID: 23234852) The American naturalist
01/01/2013
Linking plant disease risk and precipitation drivers: a dynamical systems framework. (PubMedID: 23234853) The American naturalist
01/01/2013
Species-driven phases and increasing structure in early-successional plant communities. (PubMedID: 23234854) The American naturalist
01/01/2013
Bridging the gap between neuroscientific and psychodynamic models in child and adolescent psychiatry. (PubMedID: 23164125) Child and adolescent psychiatric clinics of North America
01/01/2013
The contemporary psychodynamic developmental perspective. (PubMedID: 23164126) Child and adolescent psychiatric clinics of North America
01/01/2013
Treating childhood trauma. (PubMedID: 23164127) Child and adolescent psychiatric clinics of North America
01/01/2013
Psychodynamic psychotherapy as treatment for depression in adolescence. (PubMedID: 23164128) Child and adolescent psychiatric clinics of North America
01/01/2013
Treatment of anxiety in children and adolescents: using child and adolescent anxiety psychodynamic psychotherapy. (PubMedID: 23164129) Child and adolescent psychiatric clinics of North America
01/01/2013
Eating disorders in adolescents: review of treatment studies that include psychodynamically informed therapy. (PubMedID: 23164130) Child and adolescent psychiatric clinics of North America
01/01/2013
Psychodynamic approaches to medically ill children and their traumatically stressed parents. (PubMedID: 23164131) Child and adolescent psychiatric clinics of North America
01/01/2013
A fresh look at psychodynamic approaches to psychopathology in children and adolescents. (PubMedID: 23164132) Child and adolescent psychiatric clinics of North America
01/01/2013
The role of microparticles in the generation of immune complexes in murine lupus. (PubMedID: 23159786) Clinical immunology (Orlando, Fla.)
01/01/2013
TNF-a is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression. (PubMedID: 23178752) Clinical immunology (Orlando, Fla.)
01/01/2013
Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer. (PubMedID: 23202541) Clinical immunology (Orlando, Fla.)
01/01/2013
The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. (PubMedID: 23202542) Clinical immunology (Orlando, Fla.)
01/01/2013
Contribution of V(H) replacement products to the generation of anti-HIV antibodies. (PubMedID: 23220404) Clinical immunology (Orlando, Fla.)
01/01/2013
The role of hyaluronic acid in SEB-induced acute lung inflammation. (PubMedID: 23246605) Clinical immunology (Orlando, Fla.)
01/01/2013
[Short-term effectiveness of suture anchor after debridement of extensor tendon insertion for recalcitrant lateral epicondylitis]. (PubMedID: 23427482) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Clinical study on patellar replacement in total knee arthroplasty]. (PubMedID: 23427483) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[An improved reduction technique for depression fractures of lateral tibial plateau]. (PubMedID: 23427484) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Mini external fixation device for comminuted open fractures of metacarpal and phalange]. (PubMedID: 23427485) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Elastic stable intramedullary nailing for treatment of benign lesions of humerus complicating by pathological fracture in children]. (PubMedID: 23427486) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Comparison of two surgical methods for aseptic nonunions of femoral shaft orthopaedic surgery]. (PubMedID: 23427487) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Non-operation related risk factors of wound complications of calcaneal fractures using lateral extensive L-shaped incision]. (PubMedID: 23427488) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Clinical observation of surgical management for recurrent giant cell tumor of bone]. (PubMedID: 23427489) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Bipolar prosthetic replacement for proximal femoral tumors]. (PubMedID: 23427490) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Combined epiphyseal preservation and autograft bone transfer in treatment of children osteosarcoma]. (PubMedID: 23427491) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Research progress of three-dimensional digital model for repair and reconstruction of knee joint]. (PubMedID: 23427492) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Research progress of location marker of rotational alignment of distal femur]. (PubMedID: 23427493) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Contrastive analysis of neck axial symptoms after hybrid surgery or traditional anterior cervical discectomy and fusion for treatment of two-level cervical disease]. (PubMedID: 23427494) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Influence of intraoperative cervical posture in single segmental cervical disc replacement on restoration of cervical curve in neutral position]. (PubMedID: 23427495) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Reconstruction of zygomatic-facial massive defect using modified bilobed flap after resection of skin cancer]. (PubMedID: 23427496) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Use of perineal h-shaped incision in laparoscopic peritoneum vaginoplasty]. (PubMedID: 23427497) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
D-MELD, a strong and accurate tool to guide donor-2-recipient matching. (PubMedID: 23792516) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Differential response to LPS isotypes induced platelet activation mediated by Toll-like receptor (TLR)-4. (PubMedID: 23168607) Clinical immunology (Orlando, Fla.)
01/01/2013
The World Federation of Hemophilia guideline on management of haemophilia. (PubMedID: 23231015) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Development of factor VIII inhibitors in two patients with moderate haemophilia A. (PubMedID: 23171275) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Successful treatment with thalidomide of a patient with congenital factor V deficiency and factor V inhibitor with recurrent gastrointestinal bleeding from small bowel arteriovenous malformations. (PubMedID: 23171429) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Mayer-Rokitansky-Kuster-Hauser syndrome with type 3 von Willebrand's disease: a case report and review of literature. (PubMedID: 23167253) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
TACI mutation p.Lys154Ter identified in Good Syndrome. (PubMedID: 23165285) Clinical immunology (Orlando, Fla.)
01/01/2013
Simple and accurate bedside diagnostic kit for determining haemophilia A and B: a revised version. (PubMedID: 23088419) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review. (PubMedID: 23051581) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Assessment of self-esteem levels of Turkish patients with severe haemophilia A: Ankara Hospital experience. (PubMedID: 23020158) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Development and characterization of coated-microparticles based on whey protein/alginate using the Encapsulator device. (PubMedID: 22393914) Drug development and industrial pharmacy
01/01/2013
Comparison of pharmacokinetics in beagle dogs of nimesulide bilayer tablets with dispersible tablets. (PubMedID: 22397600) Drug development and industrial pharmacy
01/01/2013
Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization. (PubMedID: 22397675) Drug development and industrial pharmacy
01/01/2013
Comparison of a rational vs. high throughput approach for rapid salt screening and selection. (PubMedID: 22380522) Drug development and industrial pharmacy
01/01/2013
Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. (PubMedID: 22369145) Drug development and industrial pharmacy
01/01/2013
Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. (PubMedID: 22372865) Drug development and industrial pharmacy
01/01/2013
Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). (PubMedID: 22372916) Drug development and industrial pharmacy
01/01/2013
Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. (PubMedID: 22348774) Drug development and industrial pharmacy
01/01/2013
Prediction of acetaminophen's solubility in poly(ethylene oxide) at room temperature using the Flory-Huggins theory. (PubMedID: 22356356) Drug development and industrial pharmacy
01/01/2013
Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone. (PubMedID: 22335586) Drug development and industrial pharmacy
01/01/2013
In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system. (PubMedID: 22339081) Drug development and industrial pharmacy
01/01/2013
Physico chemical characterization of a novel anti-cancer agent and its comparison to Taxol(®). (PubMedID: 22339150) Drug development and industrial pharmacy
01/01/2013
Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity. (PubMedID: 22339172) Drug development and industrial pharmacy
01/01/2013
Improvement of dissolution and bioavailability of Ginsenosides by hot melt extrusion and cogrinding. (PubMedID: 22339205) Drug development and industrial pharmacy
01/01/2013
In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions. (PubMedID: 22339718) Drug development and industrial pharmacy
01/01/2013
Predictive factors for pediatric patients requiring massive blood transfusion during living donor liver transplantation. (PubMedID: 23999839) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells. (PubMedID: 23989060) Experimental & molecular medicine
01/01/2013
Signal-To-Noise-Optimal scaling of heterogenous population codes. (PubMedID: 23984844) Network (Bristol, England)
01/01/2013
The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation. (PubMedID: 23982418) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Environment, leptin sensitivity, and hypothalamic plasticity. (PubMedID: 23970977) Neural plasticity
01/01/2013
Signaling mechanisms of glucose-induced F-actin remodeling in pancreatic islet ß cells. (PubMedID: 23969997) Experimental & molecular medicine
01/01/2013
Epithelioid hemangioendothelioma of the liver: The role of hepatobiliary phase imaging for the preoperative diagnosis and qualification of patients for liver transplantation - preliminary experience. (PubMedID: 23965576) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Delayed graft function in living donor kidney transplantation. (PubMedID: 23965661) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. (PubMedID: 23949442) Experimental & molecular medicine
01/01/2013
Short tandem repeat analysis of host's hepatocellular carcinoma by laser microdissection confirms the validity of safety procedures in liver transplantation: a forensic case. (PubMedID: 23934477) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Crosstalk of inflammatory mediators and lipid parameters as early markers of renal dysfunction in stable renal transplant recipients with regard to immunosuppression. (PubMedID: 23946969) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Microcompartments and protein machines in prokaryotes. (PubMedID: 23920489) Journal of molecular microbiology and biotechnology
01/01/2013
Bacterial intracellular sulfur globules: structure and function. (PubMedID: 23920490) Journal of molecular microbiology and biotechnology
01/01/2013
Gas Vesicles across Kingdoms: A Comparative Solid-State Nuclear Magnetic Resonance Study. (PubMedID: 23920491) Journal of molecular microbiology and biotechnology
01/01/2013
The Shells of BMC-Type Microcompartment Organelles in Bacteria. (PubMedID: 23920492) Journal of molecular microbiology and biotechnology
01/01/2013
Eut bacterial microcompartments: insights into their function, structure, and bioengineering applications. (PubMedID: 23920494) Journal of molecular microbiology and biotechnology
01/01/2013
Prokaryotic proteasomes: nanocompartments of degradation. (PubMedID: 23920495) Journal of molecular microbiology and biotechnology
01/01/2013
Control of Protein Function through Regulated Protein Degradation: Biotechnological and Biomedical Applications. (PubMedID: 23920496) Journal of molecular microbiology and biotechnology
01/01/2013
Focus on membrane differentiation and membrane domains in the prokaryotic cell. (PubMedID: 23920497) Journal of molecular microbiology and biotechnology
01/01/2013
Molecular motors in bacterial secretion. (PubMedID: 23920498) Journal of molecular microbiology and biotechnology
01/01/2013
Cellulosome complexes: natural biocatalysts as arming microcompartments of enzymes. (PubMedID: 23920499) Journal of molecular microbiology and biotechnology
01/01/2013
Gene expression patterns underlying the reinstatement of plasticity in the adult visual system. (PubMedID: 23936678) Neural plasticity
01/01/2013
Evolution to twice daily bolus intravenous tacrolimus: Optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. (PubMedID: 23921892) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Cyanobacterial Carboxysomes: Microcompartments that Facilitate CO2 Fixation. (PubMedID: 23920493) Journal of molecular microbiology and biotechnology
01/01/2013
TDAG51 deficiency promotes oxidative stress-induced apoptosis through the generation of reactive oxygen species in mouse embryonic fibroblasts. (PubMedID: 23928855) Experimental & molecular medicine
01/01/2013
System consolidation of spatial memories in mice: effects of enriched environment. (PubMedID: 23936679) Neural plasticity
01/01/2013
Prevalence of the coronary artery disease risk factors and 10-year risk of cardiovascular mortality based on HeartScore in people qualified for kidney donation. (PubMedID: 23912481) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Characterizing affinity epitopes between prion protein and ß-amyloid using an epitope mapping immunoassay. (PubMedID: 23907583) Experimental & molecular medicine
01/01/2013
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up. (PubMedID: 23896824) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
AMP-activated protein kinase as a key molecular link between metabolism and clockwork. (PubMedID: 23887727) Experimental & molecular medicine
01/01/2013
Persistent ascites after liver transplantation: etiology, treatment and impact on survival. (PubMedID: 23881303) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Reactive oxygen species regulate context-dependent inhibition of NFAT5 target genes. (PubMedID: 23867654) Experimental & molecular medicine
01/01/2013
Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy. (PubMedID: 23872516) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Altered functional connectivity of cognitive-related cerebellar subregions in well-recovered stroke patients. (PubMedID: 23862075) Neural plasticity
01/01/2013
Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. (PubMedID: 23862076) Neural plasticity
01/01/2013
The role of dentate gyrus neurogenesis in neuropsychiatric disorders. (PubMedID: 23864960) Neural plasticity
01/01/2013
Ultrasonic assessment of females with carpal tunnel syndrome proved by nerve conduction study. (PubMedID: 23864961) Neural plasticity
01/01/2013
Noninvasive strategies to promote functional recovery after stroke. (PubMedID: 23864962) Neural plasticity
01/01/2013
Is sleep essential for neural plasticity in humans, and how does it affect motor and cognitive recovery? (PubMedID: 23840970) Neural plasticity
01/01/2013
Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. (PubMedID: 23840971) Neural plasticity
01/01/2013
Neural pathways conveying novisual information to the visual cortex. (PubMedID: 23840972) Neural plasticity
01/01/2013
Altered functional connectivity of the primary visual cortex in subjects with amblyopia. (PubMedID: 23844297) Neural plasticity
01/01/2013
Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats. (PubMedID: 23827952) Experimental & molecular medicine
01/01/2013
A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis. (PubMedID: 23846333) Experimental & molecular medicine
01/01/2013
Factors influencing long-term quality of life and depression in German liver transplant recipients: a single-centre cross-sectional study. (PubMedID: 23817439) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Comparision of benefits of early, delayed, and no administration of G-CSF after autologous peripheral blood stem cell transplantation in lymphoma patients. (PubMedID: 23817440) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Feasibility of laparoscopic orthotopic kidney transplantation: initial research with a pig model. (PubMedID: 23831845) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. (PubMedID: 23845965) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
The influence of clinical donor factors on acute rejection among lung and kidney recipients from the same multi-organ donor. (PubMedID: 23857357) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Physiology and plasticity of interhemispheric connections. (PubMedID: 23766920) Neural plasticity
01/01/2013
Trains of epidural DC stimulation of the cerebellum tune corticomotor excitability. (PubMedID: 23766921) Neural plasticity
01/01/2013
Journal of Women & Aging. From the editor. (PubMedID: 23767836) Journal of women & aging
01/01/2013
A multilevel perspective on gender differences in the relationship between poverty status and depression among older adults in the United States. (PubMedID: 23767837) Journal of women & aging
01/01/2013
Using changes in life satisfaction and health to predict the survival status among older men and women in Taiwan. (PubMedID: 23767838) Journal of women & aging
01/01/2013
Subsidized child care by grandparents: profiles of caregivers in an emerging public service context. (PubMedID: 23767839) Journal of women & aging
01/01/2013
Physical activity (PA) among middle-aged women: initial and current influences and patterns of participation. (PubMedID: 23767840) Journal of women & aging
01/01/2013
Perception of aging and ageism among women in Qatar. (PubMedID: 23767841) Journal of women & aging
01/01/2013
Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils. (PubMedID: 23764954) Experimental & molecular medicine
01/01/2013
Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. (PubMedID: 23788131) Experimental & molecular medicine
01/01/2013
Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes. (PubMedID: 23807304) Experimental & molecular medicine
01/01/2013
Liver transplantation for intra- and extrahepatic cholangiocarcinoma. (PubMedID: 23792495) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
High graft protection and low incidences of infections, malignancies and other adverse effects with intra-operative high dose ATG-induction: a single centre cohort study of 760 cases. (PubMedID: 23792496) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Education in organ donation among students in Germany - results of an intervention study. (PubMedID: 23792497) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet. (PubMedID: 23792498) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation. (PubMedID: 23792499) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation. (PubMedID: 23792500) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Obstructive uropathy secondary to incisional herniation of a transplant ureter - case report and review of literature. (PubMedID: 23792501) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation. (PubMedID: 23792502) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Children undergoing liver transplantation for treatment of inherited metabolic diseases are prone to higher oxidative stress, complement activity and transforming growth factor-ß1. (PubMedID: 23792503) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. (PubMedID: 23792504) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Role of platelets in the modulation of kidney allograft recipients' immune systems. (PubMedID: 23792505) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Program of laparoscopic living-donor nephrectomy with retroperitoneoscopic access - a Polish single-center experience - success or disappointment? (PubMedID: 23792506) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Incidence of malignancies in cardiac allograft recipients - a single-center experience. (PubMedID: 23792507) Annals of transplantation : quarterly of the Polish Transplantation Society
01/01/2013
Altered white matter integrity in the congenital and late blind people. (PubMedID: 23710371) Neural plasticity
01/01/2013
Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model. (PubMedID: 23738148) Neural plasticity
01/01/2013
Case study of ecstatic meditation: fMRI and EEG evidence of self-stimulating a reward system. (PubMedID: 23738149) Neural plasticity
01/01/2013
Brain connectivity plasticity in the motor network after ischemic stroke. (PubMedID: 23738150) Neural plasticity
01/01/2013
Computing loss of efficiency in optimal Bayesian decoders given noisy or incomplete spike trains. (PubMedID: 23742213) Network (Bristol, England)
01/01/2013
Retraction: Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury. (PubMedID: 23703572) Experimental & molecular medicine
01/01/2013
B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic ß-cells. (PubMedID: 23703573) Experimental & molecular medicine
01/01/2013
Functional proteomics, human genetics and cancer biology of GIPC family members. (PubMedID: 23743496) Experimental & molecular medicine
01/01/2013
Small Cationic Antimicrobial Peptidomimetics: Emerging Candidate for the Development of Potential Anti-infective Agents. (PubMedID: 23656460) Current pharmaceutical design
01/01/2013
Perioperative management of intracranial aneurysm and subarachnoid hemorrhage. (PubMedID: 23688043) Current pharmaceutical design
01/01/2013
[Study of using an individualized treatment strategy to treat patients with chronic hepatitis C]. (PubMedID: 23663758) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
[PD-1 expression in HBcAg-specific CD8+ T cells of adolescents with chronic HBV infection]. (PubMedID: 23663759) Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
01/01/2013
Stochastic resonance induced by exogenous noise in a model of a neuronal network. (PubMedID: 23654221) Network (Bristol, England)
01/01/2013
Statement on matching language to the type of evidence used in describing outcomes data. (PubMedID: 23527393) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
G protein signaling in the parasite Entamoeba histolytica. (PubMedID: 23519208) Experimental & molecular medicine
01/01/2013
Phosphatidylinositol 4-phosphate 5-kinase a negatively regulates nerve growth factor-induced neurite outgrowth in PC12 cells. (PubMedID: 23538529) Experimental & molecular medicine
01/01/2013
Glyceollins, a novel class of soybean phytoalexins, inhibit SCF-induced melanogenesis through attenuation of SCF/c-kit downstream signaling pathways. (PubMedID: 23559126) Experimental & molecular medicine
01/01/2013
ISG15: leading a double life as a secreted molecule. (PubMedID: 23579383) Experimental & molecular medicine
01/01/2013
The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis. (PubMedID: 23598593) Experimental & molecular medicine
01/01/2013
MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis. (PubMedID: 23619188) Experimental & molecular medicine
01/01/2013
Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. (PubMedID: 23640545) Experimental & molecular medicine
01/01/2013
Autophagic failure promotes the exocytosis and intercellular transfer of a-synuclein. (PubMedID: 23661100) Experimental & molecular medicine
01/01/2013
Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice. (PubMedID: 23680658) Experimental & molecular medicine
01/01/2013
From the editor. (PubMedID: 23488646) Journal of women & aging
01/01/2013
Self-regulatory driving behaviors: gender and transportation support effects. (PubMedID: 23488647) Journal of women & aging
01/01/2013
The Swedish tant: a marker of female aging. (PubMedID: 23488648) Journal of women & aging
01/01/2013
"There's really no other option": Italian Australians' experiences of caring for a family member with dementia. (PubMedID: 23488649) Journal of women & aging
01/01/2013
Sexuality and HIV/AIDS: an exploration of older heterosexual women's knowledge levels. (PubMedID: 23488650) Journal of women & aging
01/01/2013
Effect of soy isolate protein and resistance exercises on muscle performance and bone health of osteopenic/osteoporotic post-menopausal women. (PubMedID: 23488651) Journal of women & aging
01/01/2013
Different uptake of gentamicin through TRPV1 and TRPV4 channels determines cochlear hair cell vulnerability. (PubMedID: 23470714) Experimental & molecular medicine
01/01/2013
Differentiated miRNA expression and validation of signaling pathways in apoE gene knockout mice by cross-verification microarray platform. (PubMedID: 23470715) Experimental & molecular medicine
01/01/2013
A genetic effect of IL-5 receptor a polymorphism in patients with aspirin-exacerbated respiratory disease. (PubMedID: 23470716) Experimental & molecular medicine
01/01/2013
[Effect of different temperatures on system of in vitro physiological environment fostering limbs]. (PubMedID: 23427498) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Experimental study on establishment of a simple model of rats crush injury-crush syndrome]. (PubMedID: 23427499) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Chondrogenesis of adipose derived stem cells induced by misshapen auricular chondrocytes from microtia in vitro]. (PubMedID: 23427500) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Effect of rolling compression loading bioreactor on chondrogenesis of rabbit bone marrow mesenchymal stem cells with different loading parameters]. (PubMedID: 23427501) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Research progress in tissue engineered meniscus]. (PubMedID: 23427502) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Current situation and prospect of tenomodulin in tendon tissue engineering]. (PubMedID: 23427503) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Clinical research progress of direct surgical repair of lumbar spondylolysis in young patients]. (PubMedID: 23427504) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
[Present clinical research situation of adjacent segment degeneration after lumbar spinal fusion]. (PubMedID: 23427505) Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
01/01/2013
Monte Carlo methods for localization of cones given multielectrode retinal ganglion cell recordings. (PubMedID: 23194406) Network (Bristol, England)
01/01/2013
Stimulus encoding within the barn owl optic tectum using gamma oscillations vs. spike rate: a modeling approach. (PubMedID: 23406211) Network (Bristol, England)
01/01/2013
Modifying spiking precision in conductance-based neuronal models. (PubMedID: 23441599) Network (Bristol, England)
01/01/2013
From the editor. (PubMedID: 23199309) Journal of women & aging
01/01/2013
Wrinkles and sagging flesh: exploring transformations in women's sexual body image. (PubMedID: 23199310) Journal of women & aging
01/01/2013
Transforming retirement: new definitions of life after work. (PubMedID: 23199311) Journal of women & aging
01/01/2013
Initiate, bequeath, and remember: older women's transmission role within the family. (PubMedID: 23199312) Journal of women & aging
01/01/2013
Attitude toward menopause and aging: a study on postmenopausal women of West Bengal. (PubMedID: 23199313) Journal of women & aging
01/01/2013
Productive activity and life satisfaction in Korean elderly women. (PubMedID: 23199314) Journal of women & aging
01/01/2013
Active fixation mechanism complicates coronary sinus lead extraction and limits subsequent reimplantation targets. (PubMedID: 22869386) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants. (PubMedID: 23054126) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Cardiac resynchronization therapy for patients with congenital heart disease: technical challenges. (PubMedID: 23080323) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
New insights into typical atrial flutter ablation: extra-isthmus activation time on the flutter wave is predictive of extra-isthmus conduction time after isthmus block. (PubMedID: 23080324) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Cryoablation versus radiofrequency ablation for the treatment of atrioventricular nodal reentrant tachycardia: results of a prospective randomized study. (PubMedID: 23080326) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Riata lead failure with normal electrical lead parameters and normal fluoroscopic appearance. (PubMedID: 23080330) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Thermotolerance does not reduce the size or remodeling of radiofrequency lesions in the rat myocardium. (PubMedID: 23080332) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia. (PubMedID: 23090777) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Phrenic nerve palsy during ablation of atrial fibrillation using a 28-mm cryoballoon catheter: predictors and prevention. (PubMedID: 23090778) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Pulmonary vein re-isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation: safety and efficacy of a primary 2:1 bipolar/unipolar ablation mode. (PubMedID: 23097006) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation. (PubMedID: 23097007) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Ablation time efficiency and lesion volume - in vitro comparison of 4 mm, non irrigated, gold- and platinum-iridium-tip radiofrequency ablation catheters. (PubMedID: 23100094) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Impact of respiration on electroanatomical mapping of the right atrium: implication for cavotricuspid isthmus ablation. (PubMedID: 23128956) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Assessment of shoulder pain and shoulder disability in patients with implantable cardioverter-defibrillator. (PubMedID: 23179923) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Antiarrhythmic therapy--the paradigm shifts in 2012: will it be enough to result in improved health care policies? (PubMedID: 23315313) Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
01/01/2013
Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A. (PubMedID: 22762454) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Patterns of physical activity in children with haemophilia. (PubMedID: 22762509) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Liver transplant outcomes in HIV+ haemophilic men. (PubMedID: 22762561) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients. (PubMedID: 22776099) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A. (PubMedID: 22776136) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Guidelines for the management of hemophilia. (PubMedID: 22776238) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). (PubMedID: 22823000) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Morbidity and mortality in ageing HIV-infected haemophilia patients. (PubMedID: 22830609) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
US Hemophilia Treatment Center population trends 1990-2010: patient diagnoses, demographics, health services utilization. (PubMedID: 22845803) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen. (PubMedID: 22845882) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Spontaneous obturator internus muscle haematoma: a new unpublished cause of ilioipelvic pain in haemophilia. (PubMedID: 22889018) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers. (PubMedID: 22913770) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel. (PubMedID: 22913807) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries. (PubMedID: 22913831) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects. (PubMedID: 22925397) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe. (PubMedID: 22931302) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Molecular defects in the factor X gene caused by novel heterozygous mutations IVS5+1G>A and Asp409del. (PubMedID: 22931370) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. (PubMedID: 22957493) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. (PubMedID: 22958194) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Dental health and oral health-related quality of life in children with congenital bleeding disorders. (PubMedID: 22970656) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
The impact of the economic downturn and health care reform on treatment decisions for haemophilia A: patient, caregiver and health care provider perspectives. (PubMedID: 23004924) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Physician preferences for medication attributes for the prophylactic treatment of patients with severe haemophilia A with inhibitors to factor VIII. (PubMedID: 23005041) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. (PubMedID: 23005346) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China. (PubMedID: 23231016) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Progressing towards optimal management of haemophilia A patients with inhibitors. Foreword. (PubMedID: 23278992) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Inhibitors: our greatest challenge. Can we minimize the incidence? (PubMedID: 23278993) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
More than a decade of international experience with a pdFVIII/VWF concentrate in immune tolerance. (PubMedID: 23278994) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture? (PubMedID: 23278995) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution? (PubMedID: 23278996) Haemophilia : the official journal of the World Federation of Hemophilia
01/01/2013
The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. (PubMedID: 23306700) Experimental & molecular medicine
01/01/2013
ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma. (PubMedID: 23306701) Experimental & molecular medicine
01/01/2013
B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages. (PubMedID: 23306702) Experimental & molecular medicine
01/01/2013
Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback. (PubMedID: 23306703) Experimental & molecular medicine
01/01/2013
Regulation of osteogenic differentiation of human adipose-derived stem cells by controlling electromagnetic field conditions. (PubMedID: 23306704) Experimental & molecular medicine
01/01/2013
Identification of a genetic locus on chromosome 4q34-35 for type 2 diabetes with overweight. (PubMedID: 23392254) Experimental & molecular medicine
01/01/2013
Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells. (PubMedID: 23392255) Experimental & molecular medicine
01/01/2013
Activated protein C differentially regulates both viability and differentiation of osteoblasts mediated by bisphosphonates. (PubMedID: 23412516) Experimental & molecular medicine
01/01/2013
Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells. (PubMedID: 23429359) Experimental & molecular medicine
01/01/2013
Negative regulatory approaches to the attenuation of Toll-like receptor signaling. (PubMedID: 23429360) Experimental & molecular medicine
01/01/2013
Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. (PubMedID: 23116283) Drug development and industrial pharmacy
01/01/2013
3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity. (PubMedID: 23307426) Archives of pharmacal research
01/01/2013
Binding site exploration of CCR5 using in silico methodologies: a 3D-QSAR approach. (PubMedID: 23325486) Archives of pharmacal research
01/01/2013
Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation. (PubMedID: 23325487) Archives of pharmacal research
01/01/2013
Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique. (PubMedID: 23325488) Archives of pharmacal research
01/01/2013
Identification and quantification of the sedative and anticonvulsant flavone glycoside from Chrysanthemum boreale. (PubMedID: 23325489) Archives of pharmacal research
01/01/2013
Study of anti-inflammatory activities of a-D-glucosylated eugenol. (PubMedID: 23325490) Archives of pharmacal research
01/01/2013
Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents. (PubMedID: 23325491) Archives of pharmacal research
01/01/2013
Stability of citrate-capped silver nanoparticles in exposure media and their effects on the development of embryonic zebrafish (Danio rerio). (PubMedID: 23325492) Archives of pharmacal research
01/01/2013
Synthesis and anticonvulsant activity evaluation of 8-alkoxy-5-(4H-1,2,4-triazol-4-yl)quinoline derivatives. (PubMedID: 23328871) Archives of pharmacal research
01/01/2013
A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution. (PubMedID: 23328872) Archives of pharmacal research
01/01/2013
Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells. (PubMedID: 23335025) Archives of pharmacal research
01/01/2013
Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis. (PubMedID: 23338062) Archives of pharmacal research
01/01/2013
Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts. (PubMedID: 23371803) Archives of pharmacal research
01/01/2013
Evaluation of DA-9801, a new herbal drug for diabetic neuropathy, on metabolism-mediated interaction. (PubMedID: 23371804) Archives of pharmacal research
01/01/2013
Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro. (PubMedID: 23371806) Archives of pharmacal research
01/01/2013
Professor De Clercq and 25 years of international collaboration on antiviral research. (PubMedID: 22992324) Antiviral chemistry & chemotherapy
01/01/2013
Antiviral drug development--success and failure: a personal perspective with a Japanese connection. (PubMedID: 22992351) Antiviral chemistry & chemotherapy
01/01/2013
Novel thiosialosides tethered to metal nanoparticles as potent influenza A virus haemagglutinin blockers. (PubMedID: 23425865) Antiviral chemistry & chemotherapy
01/01/2013
Respiratory motion models: a review. (PubMedID: 23123330) Medical Image Analysis
01/01/2013
Intervertebral disc segmentation in MR images using anisotropic oriented flux. (PubMedID: 23107642) Medical Image Analysis
01/01/2013
Single-image super-resolution of brain MR images using overcomplete dictionaries. (PubMedID: 23102924) Medical Image Analysis
01/01/2013
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging. (PubMedID: 23084503) Medical Image Analysis
01/01/2013
Segmentation with area constraints. (PubMedID: 23084504) Medical Image Analysis
01/01/2013
Computer-aided colorectal tumor classification in NBI endoscopy using local features. (PubMedID: 23085199) Medical Image Analysis
01/01/2013
Multi-shape graph cuts with neighbor prior constraints and its application to lung segmentation from a chest CT volume. (PubMedID: 23062953) Medical Image Analysis